Building this kind of standardization into the relatively black box nature of AI development is among the priorities of The Coalition for Health AI (CHAI), which launched earlier this year.
She worked in top labs at Stanford and Harvard. Now she wants to disrupt a 100-Billion-Dollar market by rejuvenating your skin using genetic engineering.
As the body grows old, our minds are often instigated by mental decline and progressive, natural psychological aging. However, while there are very little we can do about biological aging, there are many ways to reverse psychological aging and get happ…
Aging is one single determinant of most diseases. In recent years, the biotechnology industry started using aging biology as a platform for drug discovery to discover and develop potentially blockbuster therapeutics. Dr. Michael Ringel of BCG presented…
The term Eroom’s law in pharma was coined by Dr. Jack Scannell and colleagues in 2012 in Nature Reviews Drug Discovery. It is the opposite of Moore’s law in semiconductors and states that the inflation-adjusted cost of developing a new drug roughly dou…
With the traditional pharmacy leaders, Walgreen’s and CVS, expanding virtual and in-person care, while Amazon and Walmart leverage their footprints and subscription models—the frontline healthcare wars are about to get even more competitive.
Michael Stefferson received his PhD in Physics from the University of Colorado before deciding to make the jump into machine learning (ML). Here’s why he did, and why AI can transform the future of telemental health.
While the media focuses on the negative news to grab your attention, the world is rapidly improving. One of the pockets of this positive change is Saudi Arabia which recently committed spending about 2.5% of GDP on R&D and prioritized longevity biotech…
Over 103,000 overdose death occurred last year. Thankfully, 75% of those who experience addiction eventually recover. Author and advocate Maureen Cavanagh explains how addiction can happen in any family, and how we should reinvent how we view substance…